Re:U.S. lawmakers ask Gilead to justify hepatitis C drug's $...
by coderaptor on Friday April 04, 2014 @02:44AM
(#7529723)
But, in the end, still market-bearable costs. Maybe we'd see a reduction of the costs of doing research if there weren't so much tax-payer and insurance money involved today.
[ Parent
| on HN ]
There are no comments on this comment yet.